Q/C Technologies (QCLS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Mar, 2026Executive summary
Special Meeting scheduled for November 10, 2025, to be held virtually to maximize shareholder participation and reduce costs and environmental impact.
Four key proposals will be presented: Issuance Proposal, Incentive Plan Amendment Proposal, Reverse Stock Split Proposal, and Adjournment Proposal.
Board recommends voting in favor of all proposals and has set September 18, 2025, as the record date for voting eligibility.
Voting matters and shareholder proposals
Issuance Proposal seeks approval for issuing shares and warrants related to Series H and I Preferred Stock, advisory shares, milestone shares, and consulting warrants, potentially exceeding 20% of outstanding common stock.
Incentive Plan Amendment Proposal aims to increase shares available under the 2021 Equity Incentive Plan by 1,375,000, totaling 1,400,000 shares.
Reverse Stock Split Proposal allows the Board to effect a reverse split at a ratio between 1-for-2 and 1-for-250 to maintain Nasdaq listing requirements.
Adjournment Proposal permits the meeting to be adjourned if more time is needed to solicit votes for the other proposals.
Board of directors and corporate governance
Board is responsible for soliciting proxies and recommends voting for all proposals.
Joshua Silverman serves as Executive Chairman and is the designated proxy for the meeting.
Latest events from Q/C Technologies
- Registering 6.5M shares for resale, with major dilution and capital needs amid business diversification.QCLS
Registration Filing6 Mar 2026 - Net loss increased to $27.2 million in 2024, with urgent need for new funding to sustain operations.QCLS
Q4 20246 Mar 2026 - Shareholders will vote on key proposals to enable major financings and expand authorized shares.QCLS
Proxy Filing6 Mar 2026 - Net loss narrowed, but going concern and Nasdaq compliance risks persist amid ongoing clinical development.QCLS
Q2 20256 Mar 2026 - Net loss reached $24M YTD; cash and securities at $10.6M; liquidity sufficient for 12 months.QCLS
Q3 20246 Mar 2026 - Stockholders will vote on directors, equity plan expansion, auditor ratification, and adjournment.QCLS
Proxy Filing6 Mar 2026 - Transitioned to laser-based computing for blockchain, raising $9.4M and narrowing net loss.QCLS
Q3 20256 Mar 2026 - Net loss widened to $21.3M as new financings and warrant amendments strengthened liquidity.QCLS
Q2 20246 Mar 2026 - Shareholders will vote on director elections, capital structure changes, and key governance proposals.QCLS
Proxy Filing6 Mar 2026